Veritable, L.P. Cogent Biosciences, Inc. Transaction History

Veritable, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	BUY	$9.85 - $13.24 $1,083 - $1,456	110 Added 0.64%	17,331 $205,000
Q3 2022 Nov 14, 2022	SELL	$9.39 - $16.99 $140 - $254	-15 Reduced 0.09%	17,221 $257,000
Q2 2022 Aug 15, 2022	SELL	$3.92 - $9.73 $155,953 - $387,098	-39,784 Reduced 69.77%	17,236 $155,000
Q1 2022 May 11, 2022	BUY	$5.31 - $8.7 $38,125 - $62,465	7,180 Added 14.41%	57,020 $427,000
Q2 2021 Aug 16, 2021	BUY	$7.82 - $9.3 $311,228 - $370,130	39,799 Added 396.36%	49,840 $404,000
Q1 2021 May 17, 2021	BUY	$7.47 - $12.34 $75,006 - $123,905	10,041 New	10,041 $88,000

170

113M

56.7K

40.4K

Ticker COGT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,758,300
Market Cap $585M
Description
Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found ...

Get notified when there are updates to the investment portfolio of Veritable, L.P., based on Form 13F filings with the SEC.

Stay updated on Veritable, L.P. with notifications on news.